 | • レポートコード：MRC2302B035 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、220ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートでは、2021年に841.89百万ドルであった世界の低侵襲緑内障手術装置市場規模が、2022年に981.99百万ドルになり、2027年には2,139.54百万ドルまで、年平均16.81%で成長すると予測しています。本レポートでは、低侵襲緑内障手術装置の世界市場について調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、ターゲット別（脈絡膜上腔、小柱網）分析、手術別（白内障を伴う緑内障、独立型緑内障）分析、製品別（MIGSシャント、MIGSステント）分析、エンドユーザー別（ASC、病院、眼科クリニック）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況など、以下の構成でお届けします。なお、本書には、Abbott Medical Optics, Inc.、Alcon Inc.、Allergan PLC、Bausch & Lomb Inc.、Carl-Zeiss AG、Ellex Medical Lasers Ltd.、Glaukos Corporation、InnFocus Inc.、IOPtima、iSTAR Medical、Ivantis, Inc.、Lumenis、Neomedix Corporation、New World Medical, Inc.、Optonol Ltd.、Santen Pharmaceutical Co., Ltd.、SOLX, Inc.、Topcon Corporationなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の低侵襲緑内障手術装置市場規模：ターゲット別 - 脈絡膜上腔における市場規模 - 小柱網における市場規模 ・世界の低侵襲緑内障手術装置市場規模：手術別 - 白内障を伴う緑内障における市場規模 - 独立型緑内障における市場規模 ・世界の低侵襲緑内障手術装置市場規模：製品別 - MIGSシャントの市場規模 - MIGSステントの市場規模 ・世界の低侵襲緑内障手術装置市場規模：エンドユーザー別 - ASCにおける市場規模 - 病院における市場規模 - 眼科クリニックにおける市場規模 ・世界の低侵襲緑内障手術装置市場規模：地域別 - 南北アメリカの低侵襲緑内障手術装置市場規模 アメリカの低侵襲緑内障手術装置市場規模 カナダの低侵襲緑内障手術装置市場規模 ブラジルの低侵襲緑内障手術装置市場規模 ... - アジア太平洋の低侵襲緑内障手術装置市場規模 日本の低侵襲緑内障手術装置市場規模 中国の低侵襲緑内障手術装置市場規模 インドの低侵襲緑内障手術装置市場規模 韓国の低侵襲緑内障手術装置市場規模 台湾の低侵襲緑内障手術装置市場規模 ... - ヨーロッパ/中東/アフリカの低侵襲緑内障手術装置市場規模 イギリスの低侵襲緑内障手術装置市場規模 ドイツの低侵襲緑内障手術装置市場規模 インドの低侵襲緑内障手術装置市場規模 フランスの低侵襲緑内障手術装置市場規模 ロシアの低侵襲緑内障手術装置市場規模 ... - その他地域の低侵襲緑内障手術装置市場規模 ・競争状況 ・企業情報 |
The Global Minimally Invasive Glaucoma Surgery Devices Market size was estimated at USD 841.89 million in 2021 and expected to reach USD 981.99 million in 2022, and is projected to grow at a CAGR 16.81% to reach USD 2,139.54 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Minimally Invasive Glaucoma Surgery Devices to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Target, the market was studied across Suprachoroidal Space and Trabecular Meshwork.
Based on Surgery, the market was studied across Glaucoma in Conjunction with Cataract and Stand Alone Glaucoma.
Based on Product, the market was studied across MIGS Shunt and MIGS Stent.
Based on End-User, the market was studied across Ambulatory Surgical Center, Hospital, and Ophthalmology Clinic.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Minimally Invasive Glaucoma Surgery Devices market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Minimally Invasive Glaucoma Surgery Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Minimally Invasive Glaucoma Surgery Devices Market, including Abbott Medical Optics, Inc., Alcon Inc., Allergan PLC, Bausch & Lomb Inc., Carl-Zeiss AG, Ellex Medical Lasers Ltd., Glaukos Corporation, InnFocus Inc., IOPtima, iSTAR Medical, Ivantis, Inc., Lumenis, Neomedix Corporation, New World Medical, Inc., Optonol Ltd., Santen Pharmaceutical Co., Ltd., SOLX, Inc., and Topcon Corporation.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Minimally Invasive Glaucoma Surgery Devices Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Minimally Invasive Glaucoma Surgery Devices Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Minimally Invasive Glaucoma Surgery Devices Market?
4. What is the competitive strategic window for opportunities in the Global Minimally Invasive Glaucoma Surgery Devices Market?
5. What are the technology trends and regulatory frameworks in the Global Minimally Invasive Glaucoma Surgery Devices Market?
6. What is the market share of the leading vendors in the Global Minimally Invasive Glaucoma Surgery Devices Market?
7. What modes and strategic moves are considered suitable for entering the Global Minimally Invasive Glaucoma Surgery Devices Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Patient adherence to pharmacological treatment towards rising minimally invasive surgery
5.1.1.2. Geriatric population along with increasing prevalence of glaucoma worldwide
5.1.1.3. Demand for combined glaucoma and cataract surgeries
5.1.2. Restraints
5.1.2.1. Limited availability of skilled professionals to preform minimally invasive surgery
5.1.3. Opportunities
5.1.3.1. Development of MIGS stents
5.1.3.2. Rising awareness among patients regarding glaucoma and introduction of favorable reimbursement policies
5.1.4. Challenges
5.1.4.1. Limited evidence to address the risk associate with the surgery
5.2. Cumulative Impact of COVID-19
6. Minimally Invasive Glaucoma Surgery Devices Market, by Target
6.1. Introduction
6.2. Suprachoroidal Space
6.3. Trabecular Meshwork
7. Minimally Invasive Glaucoma Surgery Devices Market, by Surgery
7.1. Introduction
7.2. Glaucoma in Conjunction with Cataract
7.3. Stand Alone Glaucoma
8. Minimally Invasive Glaucoma Surgery Devices Market, by Product
8.1. Introduction
8.2. MIGS Shunt
8.3. MIGS Stent
9. Minimally Invasive Glaucoma Surgery Devices Market, by End-User
9.1. Introduction
9.2. Ambulatory Surgical Center
9.3. Hospital
9.4. Ophthalmology Clinic
10. Americas Minimally Invasive Glaucoma Surgery Devices Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Minimally Invasive Glaucoma Surgery Devices Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Minimally Invasive Glaucoma Surgery Devices Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Abbott Medical Optics, Inc.
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Alcon Inc.
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Allergan PLC
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Bausch & Lomb Inc.
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Carl-Zeiss AG
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Ellex Medical Lasers Ltd.
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Glaukos Corporation
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. InnFocus Inc.
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. IOPtima
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. iSTAR Medical
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Ivantis, Inc.
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Lumenis
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Neomedix Corporation
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. New World Medical, Inc.
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Optonol Ltd.
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. Santen Pharmaceutical Co., Ltd.
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. SOLX, Inc.
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. Topcon Corporation
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing